Study in Stabilized Schizophrenic Patients to Evaluate the Pharmacokinetics of Risperidone and 9-Hydroxy (OH)-Risperidone When Risperidone is Administered From a Polyurethane Implant

Completed · Phase 1

Conditions studied: Schizophrenia

In brief

This is an study evaluating the safety, tolerability, and PK of EN3342 in implantation durations of 6 months.

Key facts

Study ID

NCT01774435

Run by

Endo USA Inc., a Keenova Therapeutics Company

People needed

35

Starts

2012-10-01

Expected to finish

2013-10-01

Last updated by the study team

2014-11-03

Who can join

Age: 18 and older, up to 60. Sex: any. Healthy volunteers: not accepted.

Where it is running

• CRI Lifetree — Marlton, New Jersey, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.